Form 8-K Filing for Pharma-Bio Serv, Inc.

Pharma-Bio Serv, Inc. filed a Form 8-K on June 15, 2026, to report its results of operations for the quarter ended April 30, 2026. The filing includes a press release announcing these results, furnished as Exhibit 99.1. The information provided in this Item 2.02 and Exhibit 99.1 is not considered "filed" for the purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other Company filings unless expressly stated. The filing also lists Exhibit 104 as the Cover page Interactive Data File. The report is signed by Pedro J. Lasanta, Chief Financial Officer, Vice President Finance and Administration and Secretary.